SOCKET MOBILE, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SOCKET MOBILE, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.08M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $18.76M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $17.03M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $21.24M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $23.20M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $15.70M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $19.25M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $16.45M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $21.29M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $20.79M | Mar 23, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.49M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $9.45M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $8.46M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $10.37M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $12.44M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $8.33M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $10.10M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $8.46M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $11.39M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $10.43M | Mar 23, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($14.38M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($2.24M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($1.92M) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $86.9K | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $4.47M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($3.28M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $286.6K | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | ($571.1K) | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | ($1.43M) | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $12.15M | Mar 23, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.22M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($2.46M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($3.12M) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($446.0K) | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $2.70M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($4.35M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $606.4K | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | ($586.0K) | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $2.42M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $2.56M | Mar 23, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.35M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $4.72M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $4.83M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $4.36M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $3.96M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $3.14M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $3.89M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $3.64M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $3.47M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $2.89M | Mar 23, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.25M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($521.5K) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $48.6K | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($111.4K) | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $2.14M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $804.4K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $873.5K | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $750.1K | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $2.38M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $879.8K | Mar 23, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $537.1K | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $788.3K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $2.16M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.18M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $691.8K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $536.5K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $595.2K | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $423.7K | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $412.7K | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $304.5K | Mar 23, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.44M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $27.35M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $28.74M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $28.60M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $25.58M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $15.61M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $19.46M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $18.60M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $19.85M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $21.59M | Mar 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.16M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $9.19M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $9.32M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $8.28M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $5.53M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $4.44M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $6.22M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $6.19M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $2.62M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $5.42M | Mar 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.28M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $18.16M | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | $19.42M | Mar 30, 2026 |
| FY2024 | Dec 31, 2022 | $20.32M | Mar 25, 2025 |
| FY2023 | Dec 31, 2021 | $20.05M | Mar 25, 2024 |
| FY2022 | Dec 31, 2020 | $11.17M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $13.78M | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $12.40M | Mar 23, 2021 |
| FY2018 | Dec 31, 2017 | $17.23M | Mar 28, 2019 |
| FY2018 | Dec 31, 2016 | $16.17M | Mar 28, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2019 | $4.43M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $4.43M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $4.43M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $4.43M | Mar 23, 2018 |
| FY2016 | Dec 31, 2015 | $4.43M | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | $4.43M | Mar 24, 2016 |
| FY2014 | Dec 31, 2013 | $4.43M | Mar 27, 2015 |
| FY2013 | Dec 31, 2012 | $4.43M | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $4.43M | Apr 15, 2013 |
| FY2011 | Dec 31, 2010 | $4.43M | Mar 12, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($64.55M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($50.17M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($47.93M) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($46.01M) | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | ($46.10M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($50.57M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($47.84M) | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | ($48.13M) | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | ($47.55M) | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | ($46.73M) | Mar 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.03M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $2.49M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $2.83M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $3.62M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $6.10M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $2.12M | Mar 31, 2022 |
| FY2021 | Dec 31, 2019 | $958.9K | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $1.08M | Mar 23, 2021 |
| FY2019 | Dec 31, 2017 | $3.38M | Mar 26, 2020 |
| FY2018 | Dec 31, 2016 | $1.32M | Mar 28, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 26, 2020 |
| FY2017 | Dec 31, 2017 | 0 | Mar 23, 2018 |
| FY2017 | Dec 31, 2016 | 2 | Mar 23, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 26, 2020 |
| FY2017 | Dec 31, 2017 | 0 | Mar 23, 2018 |
| FY2017 | Dec 31, 2016 | 1 | Mar 23, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.98M | Mar 30, 2026 |
| FY2024 | Mar 20, 2025 | 7.95M | Apr 14, 2025 |
| FY2025 | Dec 31, 2024 | 7.61M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 7.34M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | 7.09M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | 7.18M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 6.10M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 6.02M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | 5.88M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | 7.01M | Mar 28, 2019 |